Feature | Ryan Hiett
If the cardiologists at the University of Mississippi Medical Center (UMC) in Jackson have been facing an uphill battle ...
May 07, 2007
Feature | Mark Paquin
Examples of physicians’ declining use of drug-eluting stents are growing. According to Dr. Louis Cannon, Cardiac & ...
May 07, 2007News
May 8, 2007 - OBS Medical and Physio-Control Inc., a wholly-owned subsidiary of Medtronic Inc., announced they have ...
May 07, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Richard R. Rogoski
In the simplest of terms, a ventricular assist device (VAD) is a battery-operated mechanical pump that helps a weakened ...
May 07, 2007
Feature | Audie Lewis
Technological trendsetters within the cardiology arena have been embarking on a path of seamless integration of their ...
May 07, 2007
Technology
Arrow’s Transradial introducers provide for durable radial artery access while being vessel friendly. Our newest kit contains our .018 micro-puncture wire guide and needle set to minimize vessel trauma. The 6 French sheath and dilator track well over the smaller wire and we’ve applied a hydrophilic coating on the polyurethane sheath to enhance insertion and removal.
May 07, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
May 7, 2007 — Steven E. Nissen, M.D., chairman of the Department of Cardiovascular Medicine at Cleveland Clinic, and immediate past president of the American College of Cardiology, has been named one of the 100 Most Influential People by Time magazine. He will be featured among other "Scientists and Thinkers."
May 06, 2007News
May 7, 2007 — Australia's adult stem cell company, Mesoblast Limited, has announced that the FDA has cleared the Investigational New Drug Submission (IND) of its U.S.-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf,’ adult stem cells for patients with heart attacks.
May 06, 2007News
May 7, 2007 — Citing issues related to potentially suboptimal therapeutic dosing of paclitaxel, Conor Medsystems, LLC ...
May 06, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
May 7, 2007 — Hansen Medical Inc. has announced it has obtained FDA clearance for commercialization of the Sensei Robotic Catheter System and Artisan Control Catheter to facilitate manipulation, positioning and control of mapping catheters during electrophysiology (EP) procedures.
May 06, 2007News
May 7, 2007 Stereotaxis Inc. announced today that it has developed an innovative new single-screen user interface that ...
May 06, 2007News
May 7, 2007 — Ortho-Clinical Diagnostics Inc. has initiated a voluntary, nationwide recall of two lots of a diagnostic ...
May 06, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
May 7, 2007 — Signalife Inc. has announced that it has submitted its Fidelity 200 Cardiac Event Recorder 510K pre-market ...
May 06, 2007News
May 7, 2007 — Thoratec Corp., a global maker of products to treat cardiovascular disease, says the FDA has approved an ...
May 06, 2007News
May 3, 2007 — According to a Dow Jones News Service article published by Star Tribune, Minneapolis St. Paul, Boston Scientific Corp. is reviewing its portfolio and will consider selling parts that aren't considered strategic, long-term contributors — so stated the company's chief operating officer Wednesday.
May 02, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now